Elantan 20 mg Tablets *
Pharmacy Only: Prescription

  • Company:

    MERUS Labs
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 11 February 2022

File name

ie-smpc-ela-20-en_1644580128.pdf

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Updated adverse effect reporting details according to QRD Appendix V.

Updated on 11 February 2022

File name

ie-pil-ela-20-en_1644579919.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

Updated adverse effect reporting details according to QRD Appendix V.

Updated on 25 November 2019

File name

ie-smpc-ela-en_1574690446.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 25 November 2019

File name

ie-pil-ela-en_1574690430.pdf

Reasons for updating

  • New PIL for new product